In one paragraphArticle in Nature, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Yue XiState Key Laboratory of Metabolism and Regulation in Complex Organisms, College of Life Sciences, Wuhan University, Wuhan, China.ORCID 0000-0003-1265-6624 Waner ZengState Key Laboratory of Metabolism and Regulation in Complex Organisms, College of Life Sciences, Wuhan University, Wuhan, China.ORCID 0000-0001-9528-3661 Jie LuoState Key Laboratory of Metabolism and Regulation in Complex Organisms, College of Life Sciences, Wuhan University, Wuhan, China.ORCID 0009-0006-8176-7036 Jian ZhouNovo Nordisk Research Centre China, Novo Nordisk A/S, Beijing, China.
Lin WangNovo Nordisk Research Centre China, Novo Nordisk A/S, Beijing, China.
Jingyi SunState Key Laboratory of Metabolism and Regulation in Complex Organisms, College of Life Sciences, Wuhan University, Wuhan, China.ORCID 0009-0004-9961-8763 Zengyiting HeState Key Laboratory of Metabolism and Regulation in Complex Organisms, College of Life Sciences, Wuhan University, Wuhan, China.ORCID 0009-0009-7058-835X Weihui LiState Key Laboratory of Metabolism and Regulation in Complex Organisms, College of Life Sciences, Wuhan University, Wuhan, China.ORCID 0000-0003-3122-3453 Sitao ZhuState Key Laboratory of Metabolism and Regulation in Complex Organisms, College of Life Sciences, Wuhan University, Wuhan, China.ORCID 0000-0002-1978-8323 Wei QiSchool of Life Science and Technology, ShanghaiTech University, Shanghai, China. qiwei@shanghaitech.edu.cn.ORCID 0000-0003-0813-5316 Bao-Liang SongState Key Laboratory of Metabolism and Regulation in Complex Organisms, College of Life Sciences, Wuhan University, Wuhan, China. blsong@whu.edu.cn.ORCID 0000-0002-6397-5935 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
The prevalence of metabolic-dysfunction-associated steatohepatitis (MASH) is rising globally, yet effective treatments remain limited
Indexed as
Fatty LiverMembrane GlycoproteinsAnimalsDisease ProgressionEye ProteinsFemaleGPI-Linked ProteinsHepatocytesHumansLipogenesisLiverMaleMAP Kinase Signaling SystemMiceMice, Inbred C57BLPPAR gammaEye ProteinsGPI-Linked ProteinsGPNMB protein, humanGpnmb protein, mouseMembrane GlycoproteinsPPAR gamma
What Socratic holds
Textmetadata
Read underepoch 390